Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy

Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy

Abstract Background Anthracycline-induced cardiac dysfunction (ACD) is a notorious side effect of anticancer treatment. It has been described as a phenomenon of a continuous progressive decline of cardiac function, eventually leading to dilated cardiomyopathy (DCM). This progressive nature suggests...

Full description

Bibliographic Details
Main Authors: Janine A. M. Kamphuis, Marijke Linschoten, Maarten J. Cramer, Pieter A. Doevendans, Folkert W. Asselbergs, Arco J. Teske
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cardio-Oncology
Subjects:
Heart failure
Anthracyclines
Cardiac dysfunction
Cardiac effects of cancer treatment
Online Access:http://link.springer.com/article/10.1186/s40959-020-00079-3

Internet

http://link.springer.com/article/10.1186/s40959-020-00079-3

Similar Items